Jupiter Neurosciences

Jupiter Neurosciences Goodwill

Goodwill of Jupiter Neurosciences (JUNS) as of Oct 19, 2026.

Goodwill

-USD

Last updated:

Goodwill of Jupiter Neurosciences is 2026 - USD. Goodwill of Jupiter Neurosciences was 2025 - USD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jupiter Neurosciences Stock analysis

What does Jupiter Neurosciences do? Jupiter Neurosciences Inc, based in Palm Beach Gardens, Florida, is a clinical-stage pharmaceutical company focused on developing treatments for neuro-inflammation. The company, with four employees, has developed JOTROL, a micellar resveratrol formulation targeting rare diseases such as Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and MELAS, as well as broader conditions like Parkinson's Disease and early Alzheimer’s. JOTROL, delivered in 100mg soft gel capsules, is licensed globally from Aquanova AG for development and distribution. Jupiter Neurosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jupiter Neurosciences stock

On Eulerpool you can find the complete historical development of Goodwill Jupiter Neurosciences since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Jupiter Neurosciences historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Jupiter Neurosciences

All Key Metrics — Jupiter Neurosciences